Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY

OBJECTIVE: A comprehensive picture of pegvisomant use for treating acromegaly in routine clinical practice in different countries is lacking. We aimed, therefore, to document country-specific behaviors in real-life pegvisomant use, and the main safety and effectiveness outcomes in the ACROSTUDY. DES...

Descripción completa

Detalles Bibliográficos
Autores principales: Grottoli, S., Bianchi, A., Bogazzi, F., Bona, C., Carlsson, M. O., Colao, A., Dassie, F., Giampietro, A., Gomez, R., Granato, S., Maffei, P., Pivonello, R., Prencipe, N., Ragonese, M., Urbani, C., Cannavò, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270309/
https://www.ncbi.nlm.nih.gov/pubmed/35359232
http://dx.doi.org/10.1007/s40618-022-01789-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270309/
https://www.ncbi.nlm.nih.gov/pubmed/35359232
http://dx.doi.org/10.1007/s40618-022-01789-4

Ejemplares similares